|
300+
In-person attendees
|
66%
C-suite, MD or VP level seniority
|
20
countries represented
|
2
days
|
Competing for growth in a changing global market
Join pharmaceutical and biotech chief executives, investors, policymakers and healthcare leaders to examine the forces reshaping the global medicines industry. From drug pricing and shifting investment patterns to AI, dealmaking and patient access, the FT Global Pharma and Biotech Summit offers independent, FT-led discussions and opportunities to connect with decision-makers from across the sector.
What to expect at the Global Pharma and Biotech Summit?
The FT Global Pharma & Biotech Summit convenes senior figures from pharmaceutical and biotechnology companies, alongside investors, regulators, policymakers and healthcare providers, for strategic discussion in London. Through FT-moderated CEO interviews, panel debates and networking, the summit examines the commercial, political and technological developments shaping the future of medicine. The programme brings a global business perspective to questions of R&D investment, pipeline renewal, biotech financing, AI adoption, drug pricing and patient access, connecting the people developing innovative treatments with those funding, regulating and delivering them.
What key themes will we discuss?
Global competition and life sciences investment: How are geopolitical shifts, industrial policy and changing market dynamics influencing where pharmaceutical companies invest, develop and manufacture medicines?
Pipeline renewal, biotech financing and dealmaking: Where will the next sources of growth emerge as patent expiries, R&D costs and evolving investment conditions reshape the industry?
AI and the future of pharmaceutical innovation: Where are AI and emerging technologies delivering measurable results, and how are they changing drug development, productivity and pharmaceutical business models?
Drug pricing, regulation and market access How can pharmaceutical companies, governments and healthcare systems balance incentives for innovation with affordability, sustainable healthcare spending and patient access?
Patients, trust and the future of healthcare: How are changing patient expectations, digital health technologies and new models of care reshaping the relationship between pharmaceutical companies, clinicians and patients?

View other similar events in the sector
Gain buissness-critical knowledge, and network with industry-leading executives.
We're here to help

HEAD OF CONTENT OPERATIONS, SENIOR CONTENT POERTFOLIO MANAGER
ben.graham@ft.com
DELEGATE ENQUIRIES & HELP
BILLY WARVILLE
DELEGATE SALES MANAGER
william.warville@ft.com
+44 (0) 207 775 6653
(9.30am - 5.30pm (UK) Monday - Friday)
SPONSORSHIP OPPORTUNITIES
RACHEL JOY
DELEGATE SALES MANAGER COMMERCIAL PORTFOLIO MANAGER - PHARMA AND BIOTECH AND SUSTAINABILITY
rachel.joy@ft.com
